ストックスクリーナーアプリを入手
3.80
4.90%
-0.08
前日終値:
$3.88
開ける：
$3.91
24時間の取引高:
1.68M
Relative Volume:
1.13
時価総額：
$99.12M
収益：
-
当期純損益:
$-30.26M
株価収益率:
-1.8627
EPS:
-2.04
ネットキャッシュフロー:
$-24.69M
1週間 パフォーマンス:
+57.69%
1か月 パフォーマンス:
+70.05%
6か月 パフォーマンス:
+83.58%
1年 パフォーマンス:
-45.66%
1日の値動き範囲:
$3.4687
$4.00
1週間の範囲:
$2.3559
$4.00
52週間の値動き範囲:
$1.11
$7.52
Annovis Bio Inc Stock (ANVS) Company Profile
名前
Annovis Bio Inc
セクター
電話
484-875-3192
住所
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
ANVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
3.74 | 102.83M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.01 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.11 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.15 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.89 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.22 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-10 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2024-10-25 | アップグレード | Maxim Group | Hold → Buy |
| 2023-12-29 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
Annovis Bio Inc (ANVS) 最新ニュース
Will Annovis Bio Inc. stock attract long term capital inflows2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
How Annovis Bio Inc. stock reacts to stronger dollarJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Annovis Bio Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - earlytimes.in
How Annovis Bio Inc. stock reacts to monetary easingTake Profit & Verified Momentum Watchlists - newser.com
Why Annovis Bio Inc. stock fits value portfoliosWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Can Annovis Bio Inc. stock deliver sustainable ROEWeekly Stock Report & Daily Volume Surge Trade Alerts - newser.com
Will Annovis Bio Inc. stock benefit from automationJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
Will Annovis Bio Inc. stock outperform Dow JonesShare Buyback & Detailed Earnings Play Alerts - newser.com
Why Annovis Bio Inc. stock is a must watch tickerShare Buyback & Scalable Portfolio Growth Ideas - newser.com
How Annovis Bio Inc. stock compares with market leadersJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Is Annovis Bio Inc. stock attractive for passive investors2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
How Annovis Bio Inc. stock compares with top peers2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
Annovis Stock Rises After Company Confirms Meeting With Regulators To Discuss Drug In Treating Parkinson's Disease Dementia - MSN
Can momentum traders help lift Annovis Bio Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com
FDA to hear plan for buntanetap as Parkinson’s dementia treatment - Parkinson's News Today
What does recent volatility data suggest for Annovis Bio Inc.July 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Annovis Bio Inc. stock volume spike explainedJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Can Annovis Bio Inc. stock deliver consistent EPS growth2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com
Applying Wyckoff theory to Annovis Bio Inc. stockJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise - MyChesCo
Why retail traders accumulate Annovis Bio Inc. stockQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com
How geopolitical risks impact Annovis Bio Inc. stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Is a relief rally coming for Annovis Bio Inc. holdersPortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Annovis Bio Shares Skyrocket Following Positive Phase 3 Results for Parkinson’s Treatment - StocksToTrade
Annovis Bio Inc (ANVS) 財務データ
収益
当期純利益
現金流量
EPS
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):